@markgerstein: Navin mentions: Tracing the tumor lineage
http://t.co/pDTQBxmd54 Has nice schematic showing different tumor progression models #BTGCG14
http://www.sciencedirect.com/science/article/pii/S1574789110000323?via=ihub
@markgerstein: Navin mentions: Tracing the tumor lineage
http://t.co/pDTQBxmd54 Has nice schematic showing different tumor progression models #BTGCG14
http://www.sciencedirect.com/science/article/pii/S1574789110000323?via=ihub
@markgerstein: .nlbigas mentions: OncodriveCLUST: exploiting the [local] positional clustering of somatic mutations…
http://t.co/JbMYp6C7bF #BTGCG14
http://bioinformatics.oxfordjournals.org/content/29/18/2238.long
@markgerstein: .@nlbigas mentions: Evolution of the cancer genome http://t.co/DLwrOlzqch Drivers provide selective advantage #BTGCG14
@markgerstein: Korbel mentions: Criteria for Inference of
Chromothripsis in Cancer Genome
http://t.co/TslcrZsmNv #BTGCG14
http://www.sciencedirect.com/science/article/pii/S0092867413002122
http://www.nature.com/ng/journal/vaop/ncurrent/full/ng.3101.html
An interesting report of potential non-coding drivers without actually doing any wet lab work.
“These methods identify recurrent mutations in regulatory elements upstream of PLEKHS1, WDR74 and SDHD, as well as previously identified mutations in the TERT promoter”. In the text they mention “Khurana et al. also reported WDR74 promoter mutations in 2 of the 20 prostate cancer genomes analyzed”.
Structural networks of signaling pathways
http://www.sciencedirect.com/science/article/pii/S0959440X1200070X Prism on IL10 #networks, mapping on Cosmic, disrupting mutations as drivers
The Price of Life http://contentviewer.adobe.com/s/Wired/5857345fd35d4d1f9a1f00273013f68a/WI0814_10_Folio/2000_2208IN_deathvmoney.html Nice #visualization of NIH #funding, showing emphasis on #cancer & diabetes v heart disease
contains proteomics on some of the TCGA samples
http://proteomics.cancer.gov/programs/cptacnetwork
metabric consortium
gene expression & copy number data available and survival data (on request) for the 4 main breast cancer types (basal, her2 , luma, lumb)
similar to TCGA but from the UK
Allows construction of discovery & validation sets to compare segregation of survival with mRNA level
compare segreg. of survival with inferred protein activity v mRNA level
#Singlecell #RNAseq highlights intratumoral heterogeneity http://www.sciencemag.org/content/344/6190/1396.abs Subtype classifiers variably expressed across indiv. cells
Patel AP(1), Tirosh I(2), Trombetta JJ(2), Shalek AK(2), Gillespie SM(3),
Wakimoto H(4), Cahill DP(4), Nahed BV(4), Curry WT(4), Martuza RL(4), Louis
DN(5), Rozenblatt-Rosen O(2), Suvà ML(6), Regev A(7), Bernstein BE(8).
Published Online June 12 2014
Science 20 June 2014:
Vol. 344 no. 6190 pp. 1396-1401
DOI: 10.1126/science.1254257